Menu

Filtros : "MORTALIDADE" "AstraZeneca" Removido: "Pfizer" Limpar

Filtros

Limitar por data

  • 1

1 - 2 (2 registros)

  • Artigo de periodico

    Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial (2022)

    Heerspink, Hiddo J. L; Sjostrom, C. David; Jongs, Niels; Chertow, Glenn M; Kosiborod, Mikhail; Hou, Fan Fan; McMurray, John J; Rossing, Peter; Correa-Rotter, Ricardo; Kurlyandskaya, Raisa; Noronha, Irene de Lourdes

    Fonte: European heart journal. Unidade: FM

    Assuntos: DOENÇA CRÔNICA, INSUFICIÊNCIA RENAL, MORTALIDADE, ESTUDOS RANDOMIZADOS

    Acesso à fonteAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      HEERSPINK, Hiddo J. L et al. Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial. European heart journal, v. 42, n. 13, p. 1216-1227, 2022Tradução . . Disponível em: https://doi.org/10.1093/eurheartj/ehab094. Acesso em: 27 set. 2024.

    • APA

      Heerspink, H. J. L., Sjostrom, C. D., Jongs, N., Chertow, G. M., Kosiborod, M., Hou, F. F., et al. (2022). Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial. European heart journal, 42( 13), 1216-1227. doi:10.1093/eurheartj/ehab094

    • NLM

      Heerspink HJL, Sjostrom CD, Jongs N, Chertow GM, Kosiborod M, Hou FF, McMurray JJ, Rossing P, Correa-Rotter R, Kurlyandskaya R, Noronha I de L. Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial [Internet]. European heart journal. 2022 ; 42( 13): 1216-1227.[citado 2024 set. 27 ] Available from: https://doi.org/10.1093/eurheartj/ehab094

    • Vancouver

      Heerspink HJL, Sjostrom CD, Jongs N, Chertow GM, Kosiborod M, Hou FF, McMurray JJ, Rossing P, Correa-Rotter R, Kurlyandskaya R, Noronha I de L. Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial [Internet]. European heart journal. 2022 ; 42( 13): 1216-1227.[citado 2024 set. 27 ] Available from: https://doi.org/10.1093/eurheartj/ehab094

  • Artigo de periodico

    Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015:: a novel analysis from the Global Burden of Disease Study 2015 (2017)

    Barber, Ryan M; Benseñor, Isabela Judith Martins; Lotufo, Paulo Andrade

    Fonte: Lancet. Unidade: FM

    Assuntos: MORTALIDADE, QUALIDADE DE VIDA, ATENÇÃO À SAÚDE, ÍNDICES

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      BARBER, Ryan M e BENSEÑOR, Isabela Judith Martins e LOTUFO, Paulo Andrade. Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015:: a novel analysis from the Global Burden of Disease Study 2015. Lancet, v. 390, n. 10113, p. 2627-2642, 2017Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(17)30818-8. Acesso em: 27 set. 2024.

    • APA

      Barber, R. M., Benseñor, I. J. M., & Lotufo, P. A. (2017). Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015:: a novel analysis from the Global Burden of Disease Study 2015. Lancet, 390( 10113), 2627-2642. doi:10.1016/S0140-6736(17)30818-8

    • NLM

      Barber RM, Benseñor IJM, Lotufo PA. Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015:: a novel analysis from the Global Burden of Disease Study 2015 [Internet]. Lancet. 2017 ; 390( 10113): 2627-2642.[citado 2024 set. 27 ] Available from: https://doi.org/10.1016/S0140-6736(17)30818-8

    • Vancouver

      Barber RM, Benseñor IJM, Lotufo PA. Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015:: a novel analysis from the Global Burden of Disease Study 2015 [Internet]. Lancet. 2017 ; 390( 10113): 2627-2642.[citado 2024 set. 27 ] Available from: https://doi.org/10.1016/S0140-6736(17)30818-8
  • 1

1 - 2 (2 registros)

Biblioteca Digital de Produção Intelectual da Universidade de São Paulo     2012 - 2024